Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
GlaxoSmithKline will spend $13 billion to buy Novartis’s 36.5% stake in the two drug companies’ consumer health care venture. GSK will fully own a business that includes Sensodyne toothpaste and over-the-counter pills. Vasant Narasimhan, Novartis’s new CEO, says the sale will help fuel his firm’s strategy of buying smaller pharmaceutical companies. The news came less than a week after GSK and Reckitt Benckiser both dropped out of the bidding for Pfizer’s consumer health care business, which Pfizer hopes to sell for $20 billion.
This article has been sent to the following recipient: